Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.33 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.33 |
| ▸ | KIF11 | P52732 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | ESR1 | P03372 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CRHBP | P24387 | 1/20 | 0.30 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.30 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17864869 | 0.78 | ESR1 (0.40) | ALDH1A1TDP1TSHRCA2GABRA1 | |
| SCHEMBL9621326 | 0.75 | TSHR (0.46) | ALDH1A1TDP1TSHRCA2GABRA1 | |
| SCHEMBL4667743 | 0.75 | GABRA1 (0.46) | ALDH1A1TDP1TSHRCA2GABRA1 | |
| SCHEMBL7941102 | 0.75 | ALDH1A1 (0.52) | ALDH1A1TDP1TSHRCA2GABRA1 | |
| SCHEMBL29414888 | 0.75 | GABRA1 (0.46) | ALDH1A1TDP1TSHRCA2GABRA1 | |
| SCHEMBL1679119 | 0.74 | ALDH1A1 (0.34) | ALDH1A1CA2 | |
| Methoxymethane SCHEMBL28022478 | 0.73 | ALDH1A1 (0.55) | ALDH1A1TDP1TSHRCA2GABRA1 | |
| SCHEMBL271789 | 0.73 | ALDH1A1 (0.44) | ALDH1A1TDP1TSHRCA2GABRA1 | |
| SCHEMBL10170299 | 0.73 | ALDH1A1 (0.44) | ALDH1A1TDP1TSHRCA2GABRA1 | |
| SCHEMBL6258936 | 0.72 | MAPT (0.48) | ALDH1A1TDP1CA2GABRA1GABRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2616424-B1 | METHOD FOR PRODUCING 2-METHYL-3-(4-TERT-BUTYLPHENYL)-PROPANAL HAVING HIGH PARA-ISOMER PURITY | BASF SE (DE) | 2015-08-26 | — | — | EP | disclosed |
| CN-102365393-B | Electrochemical method for producing 3 tert.-butyl benzaldehyde- dimethylacetal | BASF SE (DE) | 2014-10-29 | — | — | CN | disclosed |
| CN-102365393-B | Electrochemical method for producing 3 tert.-butyl benzaldehyde- dimethylacetal | BASF SE (DE) | 2014-10-29 | — | — | CN | disclosed |
| US-8614358-B2 | Process for preparing 2-methyl-3-(4-tert-butylphenyl)propanal with high para-isomer purity | BASF SE (DE) | 2013-12-24 | — | — | US | disclosed |
| EP-2616424-A1 | METHOD FOR PRODUCING 2-METHYL-3-(4-TERT-BUTYLPHENYL)-PROPANAL HAVING HIGH PARA-ISOMER PURITY | BASF SE (DE) | 2013-07-24 | — | — | EP | disclosed |
| US-20120071696-A1 | PROCESS FOR PREPARING 2-METHYL-3-(4-TERT-BUTYLPHENYL)PROPANAL WITH HIGH PARA-ISOMER PURITY | BASF SE (DE) | 2012-03-22 | — | — | US | disclosed |
| WO-2012034930-A1 | METHOD FOR PRODUCING 2-METHYL-3-(4-TERT-BUTYLPHENYL)-PROPANAL HAVING HIGH PARA-ISOMER PURITY | BASF SE (DE) | 2012-03-22 | — | — | WO | disclosed |
| CN-102365393-A | Electrochemical method for producing 3 tert.-butyl benzaldehyde- dimethylacetal | BASF SE | 2012-02-29 | — | — | CN | disclosed |
| CN-102365393-A | Electrochemical method for producing 3 tert.-butyl benzaldehyde- dimethylacetal | BASF SE | 2012-02-29 | — | — | CN | disclosed |
| EP-2411564-A1 | ELECTROCHEMICAL METHOD FOR PRODUCING 3 TERT.-BUTYL BENZALDEHYDE- DIMETHYLACETAL | BASF SE (DE) | 2012-02-01 | — | — | EP | disclosed |
| WO-2010108874-A1 | ELECTROCHEMICAL METHOD FOR PRODUCING 3 TERT.-BUTYL BENZALDEHYDE- DIMETHYLACETAL | BASF SE (DE) | 2010-09-30 | — | — | WO | disclosed |
| US-6315884-B1 | REDUCING PHTHALIC ACID OR PHTHALIC ACID DERIVATIVES AT CATHODE IN UNDIVIDED ELECTROLYTIC CELL AND DISSOLVED IN ELECTROLYTE; DISCHARGING ELECTROLYTE FROM ELECTROLYTIC CELL; CRYSTALLIZING PHTHALIDES FROM ELECTROLYTE AND REMOVING | BASF AKTIENGESELLSCHAFT (DE) | 2001-11-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120071696-A1 | PROCESS FOR PREPARING 2-METHYL-3-(4-TERT-BUTYLPHENYL)PROPANAL WITH HIGH PARA-ISOMER PURITY | HPD, PAH, PTMA | ALDH1A1 97/4885TDP1 1353/4885TSHR 2594/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.